National Comprehensive Cancer Network

About NCCN

Updated Patient Resources Now Available for Prostate Cancer

The National Comprehensive Cancer Network® (NCCN®) has published updated NCCN Guidelines for Patients® and NCCN Quick Guide™ sheet for Prostate Cancer. These resources are made available through support from the NCCN Foundation®.

The NCCN Guidelines for Patients®: Prostate Cancer were updated from the 2015 version to the 2016 version. Changes to the patient guide include new treatment options and modifications to molecular testing and the addition of mpMRI for active surveillance. Moreover, in some cases, active surveillance may be an option for intermediate-risk disease, and the guide now includes external radiation with ADT and docetaxel as a treatment option for high- and very-high-risk disease.

NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are easy-to-understand resources based on the same clinical practice guidelines used by health care professionals around the world to determine the best way to treat a patient with cancer. Each resource features unbiased expert guidance from the nation’s leading cancer centers designed to help people living with cancer talk with their physicians about the best treatment options for their disease. These resources are available free of charge at

NCCN Guidelines for Patients and NCCN Quick Guide™ sheets—one- to two-page summaries of key points in the patient guidelines—are written in plain language and include patient-friendly elements, such as questions to ask your doctor, a glossary of terms, and medical illustrations of anatomy, tests, and treatments. NCCN Guidelines for Patients and NCCN Quick Guide™ sheets DO NOT replace the expertise and clinical judgment of the clinician.

NCCN currently offers NCCN Guidelines for Patients for the following:  Breast, Colon, Esophageal, Kidney, NSCLC, Ovarian, Pancreatic, Prostate, and Stomach Cancers; Acute Lymphocytic Leukemia (ALL); AYA with Cancer; Chronic Lymphocytic Leukemia (CLL); Chronic Myelogenous Leukemia (CML); Hodgkin Lymphoma; Lung Cancer Screening; Malignant Pleural Mesothelioma; Myelodysplastic Syndromes (MDS); Melanoma; Multiple Myeloma; Non-Hodgkin’s Lymphomas; and Soft Tissue Sarcoma.

To download the NCCN patient education resources for Prostate Cancer, visit